SEC Form 4 · accession 0001127602-15-016088
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Martine A Rothblatt
Officer — Chairman & Co-CEO · Director
Period of report
May 4, 2015
Accepted (ET)
May 4, 2015 · 5:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2015 | M | 15,322 | $53.42 | A | 30,884 | D | |
| Common Stock | May 4, 2015 | M | 2,592 | $52.65 | A | 33,476 | D | |
| Common StockF3 | May 4, 2015 | S | 1,000 | $168.807 | D | 32,476 | D | |
| Common StockF4 | May 4, 2015 | S | 1,000 | $169.761 | D | 31,476 | D | |
| Common StockF5 | May 4, 2015 | S | 200 | $171.015 | D | 31,276 | D | |
| Common StockF6 | May 4, 2015 | S | 392 | $171.8863 | D | 30,884 | D | |
| Common Stock | holding | — | — | — | 166 | I | By Spouse | |
| Common Stock | holding | — | — | — | 594,387 | I | By Trusts |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | $53.42 | May 4, 2015 | M | 15,322 | D | Dec 31, 2012 | Dec 31, 2022 | Common Stock | 15,322 | 61,288 | D |
| Stock Options | $52.65 | May 4, 2015 | M | 2,592 | D | Dec 31, 2009 | Dec 31, 2019 | Common Stock | 2,592 | 492,833 | D |
Explanation of responses
- F1Exercise of stock options pursuant to an "exercise and hold" transaction where none of the resulting shares were sold.
- F2This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.
- F3This transaction was executed in multiple trades at prices ranging from $168.27 to $169.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $169.47 to $170.12. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5This transaction was executed in multiple trades at prices ranging from $170.70 to $171.33. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F6This transaction was executed in multiple trades at prices ranging from $171.73 to $172.07. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.